ReviewCancers2026

Choosing Between Anti-TROP2 ADCs in Advanced Breast Cancer Without Head-to-Head Evidence: A Practical Evidence-Informed Decision Framework Endorsed by the Polish Society of Clinical Oncology.

Piotr J Wysocki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.